- Home
- BNTX vs GIB Comparison
BNTX vs GIB Comparison
Compare BNTX & GIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | GIB |
|---|---|---|
| Founded | 2008 | 1976 |
| Country | Germany | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 19.5B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BNTX | GIB |
|---|---|---|
| Price | $93.95 | $91.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 3 |
| Target Price | ★ $137.40 | $117.00 |
| AVG Volume (30 Days) | ★ 1.3M | 325.2K |
| Earning Date | 11-03-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | N/A | ★ 0.55 |
| EPS | N/A | ★ 5.28 |
| Revenue | $3,698,814,972.00 | ★ $11,424,213,683.00 |
| Revenue This Year | $2.36 | $8.52 |
| Revenue Next Year | N/A | $3.31 |
| P/E Ratio | ★ N/A | $17.20 |
| Revenue Growth | 3.70 | ★ 8.43 |
| 52 Week Low | $81.20 | $84.00 |
| 52 Week High | $129.27 | $122.79 |
Technical Indicators
Market Signals| Indicator | BNTX | GIB |
|---|---|---|
| Relative Strength Index (RSI) | 36.42 | 59.41 |
| Support Level | $94.52 | $89.13 |
| Resistance Level | $97.35 | $92.32 |
| Average True Range (ATR) | 2.51 | 1.64 |
| MACD | -0.26 | 0.20 |
| Stochastic Oscillator | 3.07 | 63.37 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.